Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Recall class: Type II
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 206 items.
Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-05-16
Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
RecallHealth product recall | 2024-05-16
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg
RecallHealth product recall | 2024-04-02
FOLIC ACID 1MG - Affected lots exceed or may exceed the acceptable intake limit for N-nitroso-folic acid.
RecallHealth product recall | 2024-03-12
TEVA-DILTIAZEM XC: Out of specification
RecallHealth product recall | 2024-02-07
JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose
RecallHealth product recall | 2024-01-24
PEDIATRIX ORAL SOLUTION 100mg: Out of specification
RecallHealth product recall | 2024-01-15
Life Brand Long Lasting Decongestant Nasal Spray 15 mL: Labelled with incorrect Drug Facts Table
RecallHealth product recall | 2024-01-04
Life Brand Decongestant Nasal Spray 20 mL: Labelled with incorrect Drug Facts Table
RecallHealth product recall | 2024-01-04
Privigen: Series of adverse reactions
RecallHealth product recall | 2023-12-21
Claritin® Kids Rapid Dissolve 5 mg: Potential contamination
RecallHealth product recall | 2023-12-20
Hadalabo Pearl Barley Facial Foam: Unauthorized product
RecallHealth product recall | 2023-12-15
PMS-Perindopril: Defective seals
RecallHealth product recall | 2023-12-15
JAMP-ASA EC: out of specification
RecallHealth product recall | 2023-12-04